The orphan nuclear receptor RORα is a potential endogenous protector in renal ischemia/reperfusion injury.
Cai J, Jiao X, Fang Y, Yu X, Ding X.
Cai J, et al. Among authors: fang y.
FASEB J. 2019 Apr;33(4):5704-5715. doi: 10.1096/fj.201802248R. Epub 2019 Jan 23.
FASEB J. 2019.
PMID: 30673513
In summary, our study provides experimental evidence showing that RORalpha is a novel endogenous protector against renal I/R injury and that ROR-alpha activation is a promising therapeutic strategy for the prevention of acute kidney injury.-Cai, J., Jiao, X., Fang, Y …
In summary, our study provides experimental evidence showing that RORalpha is a novel endogenous protector against renal I/R injury and that …